Published in Parkinsonism Relat Disord on March 25, 2010
Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry (2011) 0.86
Striatal patch compartment lesions alter methamphetamine-induced behavior and immediate early gene expression in the striatum, substantia nigra and frontal cortex. Brain Struct Funct (2013) 0.79
Striatal patch compartment lesions reduce stereotypy following repeated cocaine administration. Brain Res (2015) 0.76
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord (2009) 3.56
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med (2006) 2.17
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol (2005) 1.82
The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the assessment of multiple addictions in a high-school population: prevalence and related disability. CNS Spectr (2006) 1.74
Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol (2011) 1.59
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry (2013) 1.58
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet (2006) 1.56
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat (2013) 1.53
An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease. J Alzheimers Dis (2011) 1.45
Fragile X premutation with atypical symptoms at onset. Arch Neurol (2006) 1.43
Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Neurobiol Aging (2006) 1.42
A case of brain abscess by Eikenella corrodens in a HIV-positive patient. Ann Ital Med Int (2003) 1.39
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J Neurol (2012) 1.34
Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience. Anticancer Drugs (2008) 1.28
Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord (2006) 1.25
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol (2007) 1.22
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet (2004) 1.20
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci (2009) 1.14
Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet (2005) 1.13
Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium (2006) 1.12
Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol (2008) 1.10
"Physiologic ICSI": hyaluronic acid (HA) favors selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality. Fertil Steril (2009) 1.10
Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease. PLoS One (2010) 1.06
Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurol Sci (2012) 1.06
Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin Med Genet (2004) 1.06
Sterilization of liquid nitrogen with ultraviolet irradiation for safe vitrification of human oocytes or embryos. Fertil Steril (2009) 1.06
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol (2009) 1.05
Plasma cell granuloma--an enigmatic lesion: description of an extensive intracranial case and review of the literature. Arch Pathol Lab Med (2003) 1.04
Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry (2005) 1.02
Impulsivity in the general population: a national study. J Psychiatr Res (2012) 1.02
KIBRA gene variants are associated with episodic memory performance in subjective memory complaints. Neurosci Lett (2008) 1.01
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging (2011) 1.00
Human longevity and 11p15.5: a study in 1321 centenarians. Eur J Hum Genet (2009) 1.00
Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. CNS Spectr (2006) 0.99
Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler (2009) 0.99
Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic Biol Med (2002) 0.99
Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol (2006) 0.99
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2013) 0.98
Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study. CNS Drugs (2010) 0.97
The treatment of adults with medulloblastoma: a prospective study. Int J Radiat Oncol Biol Phys (2003) 0.96
Cholesteryl ester transfer protein (CETP) I405V polymorphism and longevity in Italian centenarians. Mech Ageing Dev (2005) 0.96
Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study. CNS Drugs (2009) 0.96
Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging (2009) 0.96
The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol (2015) 0.95
Implication of sex and SORL1 variants in italian patients with Alzheimer disease. Arch Neurol (2009) 0.95
Novel parkin mutations detected in patients with early-onset Parkinson's disease. Mov Disord (2005) 0.94
SNPs in neurotrophin system genes and Alzheimer's disease in an Italian population. J Alzheimers Dis (2008) 0.94
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression. J Neurol Neurosurg Psychiatry (2011) 0.94
Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study. Psychiatry Res (2004) 0.94
Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease. J Nucl Med (2004) 0.93
Genetics of familial and sporadic Alzheimer's disease. Front Biosci (Elite Ed) (2013) 0.93
Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci Lett (2007) 0.93
Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas. J Clin Endocrinol Metab (2005) 0.93
Functional deficits of the attentional networks in autism. Brain Behav (2012) 0.92
Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease. J Nucl Med (2002) 0.92
Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT. J Nucl Med (2005) 0.92
Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci Lett (2004) 0.91
Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. Drug Alcohol Depend (2008) 0.91
How can elderly apolipoprotein E ε4 carriers remain free from dementia? Neurobiol Aging (2012) 0.91
Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease. Alzheimer Dis Assoc Disord (2005) 0.91
Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy. Ann Neurol (2004) 0.91
Mutant presenilin 1 increases the expression and activity of BACE1. J Biol Chem (2009) 0.91
Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer's disease patients and healthy controls. Antioxid Redox Signal (2011) 0.90
Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease. Mol Med (2007) 0.90
Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts. Neurobiol Aging (2006) 0.89
Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol (2008) 0.88
Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. Neurosci Lett (2002) 0.88
Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease. Neurobiol Aging (2010) 0.88
Current concepts and novel applications of LH activity in ovarian stimulation. Trends Endocrinol Metab (2003) 0.88
Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease. J Alzheimers Dis (2010) 0.88
Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. J Health Psychol (2012) 0.88
Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa. Obes Facts (2012) 0.87
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment. J Neurol Sci (2006) 0.87
Identification of new presenilin gene mutations in early-onset familial Alzheimer disease. Arch Neurol (2003) 0.87
On the multivariate nature of brain metabolic impairment in Alzheimer's disease. Neurobiol Aging (2007) 0.87
Cathepsin D expression is decreased in Alzheimer's disease fibroblasts. Neurobiol Aging (2006) 0.87
Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype. Dement Geriatr Cogn Disord (2007) 0.87
Clinical and genetic study of a large SPG4 Italian family. Mov Disord (2005) 0.86
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain (2006) 0.86
Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis. Fertil Steril (2002) 0.86
NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study. Neuropathology (2007) 0.86
Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders. Hum Mol Genet (2008) 0.85
Adult attention-deficit hyperactivity disorder and obesity: epidemiological study. Br J Psychiatry (2013) 0.85
Novel S-acyl glutathione derivatives prevent amyloid oxidative stress and cholinergic dysfunction in Alzheimer disease models. Free Radic Biol Med (2012) 0.85
Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study. J Neural Transm (Vienna) (2009) 0.85
Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J Neuropathol Exp Neurol (2004) 0.85
5-HT2A receptor gene polymorphism and eating disorders. Neurosci Lett (2002) 0.85
A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPECT measurements. Eur J Nucl Med Mol Imaging (2007) 0.84
Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane. J Mol Med (Berl) (2010) 0.84